Condition

AML (Acute Myelogenous Leukemia)

ClinicalTrials.gov condition label

Clinical trials1

Recruiting0

Common interventions4

Lead sponsors shown1

Clinical trials

1 shown

Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical TrialsNCT07474051 · 2026-01-29

ENROLLING_BY_INVITATION

Common interventions

Allo-QuadCAR01-TBIOLOGICAL1Allo-RevCAR01- T with Targeting Module R-TM123BIOLOGICAL1UniCAR02-T (IMP) With Targeting Module TM123BIOLOGICAL1UniCAR02-T-pPSMABIOLOGICAL1

Leading sponsors

AvenCell Therapeutics, Inc.1

Trial status mix

ENROLLING_BY_INVITATION1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.